Topical Zafirlukast

A Promising New Treatment for Allergic Eye Disorders

AdobeStock_315672497.jpeg
Accolade is a development-stage specialty bio-pharmaceutical company focused on developing a range of products for the treatment of atopic and inflammatory allergic conditions. Our team is dedicated to re-purposing Zafirlukast, a known Leukotriene Receptor Antagonist (LTRA) approved and marketed world-wide as Accolate®.
 
Our initial focus  is re-purposing and use of Zafirlukast for allergic eye disorders.    

 

 

©  2020 Accolade Pharma, LLC

42 Hill Road

Wilmington, DE 19806

302-427-2985